New Jersey Senate Bill S232

New Jersey 2022-2023 Regular Session

• Introduced: 1/11/22
• Refer: 1/11/22

Caption

Revises requirements for administration of vaccines to patients.

Impact

The enactment of S232 would significantly strengthen the information rights of patients regarding vaccinations. By requiring a standardized set of documents to be furnished prior to vaccine administration, the bill aims to ensure that patients are adequately informed about vaccine components and potential side effects. This could lead to more educated decision-making regarding vaccination among patients, particularly for minors, as parents or guardians will be more involved in the decision process.

Summary

Senate Bill S232 revises the administration requirements for vaccines in the state of New Jersey. Under this bill, health care practitioners must provide patients or their guardians with specific information at least 48 hours prior to administering a vaccine. This information includes a copy of the vaccine insert, a summary of vaccine ingredients prepared by the CDC, and details concerning the Vaccine Adverse Event Reporting System (VAERS), which tracks vaccine-related injuries and reports. The bill also mandates that patients must return a signed confirmation of consent for the vaccine before it can be administered.

Contention

However, the bill has stirred some controversy surrounding the implications for public health. Critics may argue that the mandatory opt-out option coupled with the detailed information provisions could discourage vaccinations, potentially leading to lower immunization rates. There are also concerns that this legislation might complicate processes for healthcare providers, who may already be under pressure to deliver vaccines efficiently. Additionally, there are discussions about how this might interact with existing school vaccination requirements, as unvaccinated children may not be allowed to attend school unless medical or religious exemptions are obtained.